170 related articles for article (PubMed ID: 30521872)
1. Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma.
Wang Z; Yan M; Li J; Long J; Li Y; Zhang H
Biochim Biophys Acta Mol Cell Res; 2019 Apr; 1866(4):566-574. PubMed ID: 30521872
[TBL] [Abstract][Full Text] [Related]
2. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
[TBL] [Abstract][Full Text] [Related]
4. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
5. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
7. CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity.
Chen RY; Yen CJ; Liu YW; Guo CG; Weng CY; Lai CH; Wang JM; Lin YJ; Hung LY
Cell Death Differ; 2020 Apr; 27(4):1259-1273. PubMed ID: 31511651
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
9. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
[TBL] [Abstract][Full Text] [Related]
11. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
Rajendran P; Ong TH; Chen L; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Hui KM; Sethi G
Clin Cancer Res; 2011 Mar; 17(6):1425-39. PubMed ID: 21131551
[TBL] [Abstract][Full Text] [Related]
12. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
13. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
[TBL] [Abstract][Full Text] [Related]
14. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
Zuo M; Li C; Lin J; Javle M
Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
Carbajo-Pescador S; Ordoñez R; Benet M; Jover R; García-Palomo A; Mauriz JL; González-Gallego J
Br J Cancer; 2013 Jul; 109(1):83-91. PubMed ID: 23756865
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide promotes angiogenesis in mice model of HCC by stimulating hepatic stellate cell activation via TLR4 pathway.
Lu Y; Xu J; Chen S; Zhou Z; Lin N
Acta Biochim Biophys Sin (Shanghai); 2017 Nov; 49(11):1029-1034. PubMed ID: 29036356
[TBL] [Abstract][Full Text] [Related]
17. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
19. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
20. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Huang B; Huang M; Li Q
Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]